FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:PRKCA-CEP112

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: PRKCA-CEP112
FusionPDB ID: 68696
FusionGDB2.0 ID: 68696
HgeneTgene
Gene symbol

PRKCA

CEP112

Gene ID

5578

201134

Gene nameprotein kinase C alphacentrosomal protein 112
SynonymsAAG6|PKC-alpha|PKCA|PKCI+/-|PKCalpha|PRKACACCDC46|MACOCO
Cytomap

17q24.2

17q24.1

Type of geneprotein-codingprotein-coding
Descriptionprotein kinase C alpha typePKC-Aaging-associated gene 6centrosomal protein of 112 kDacentrosomal protein 112kDacoiled-coil domain-containing protein 46
Modification date2020032720200313
UniProtAcc

PICK1

Main function of 5'-partner protein: 415

Q8N8E3

Main function of 5'-partner protein:
Ensembl transtripts involved in fusion geneENST idsENST00000413366, ENST00000583361, 
ENST00000580482, ENST00000317442, 
ENST00000392769, ENST00000535342, 
ENST00000537949, ENST00000541355, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score44 X 23 X 14=1416822 X 17 X 10=3740
# samples 4621
** MAII scorelog2(46/14168*10)=-4.94485844580754
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(21/3740*10)=-4.15457703710888
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: PRKCA [Title/Abstract] AND CEP112 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: PRKCA [Title/Abstract] AND CEP112 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)PRKCA(64492401)-CEP112(63848152), # samples:2
Anticipated loss of major functional domain due to fusion event.PRKCA-CEP112 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PRKCA-CEP112 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PRKCA-CEP112 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
PRKCA-CEP112 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgenePRKCA

GO:0006468

protein phosphorylation

10770950

HgenePRKCA

GO:0035408

histone H3-T6 phosphorylation

20228790

HgenePRKCA

GO:0043536

positive regulation of blood vessel endothelial cell migration

20011604

HgenePRKCA

GO:0090330

regulation of platelet aggregation

12724315



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:64492401/chr17:63848152)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across PRKCA (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across CEP112 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000413366PRKCAchr1764492401+ENST00000535342CEP112chr1763848152-1452314141018334
ENST00000413366PRKCAchr1764492401+ENST00000392769CEP112chr1763848152-1449314141018334
ENST00000413366PRKCAchr1764492401+ENST00000541355CEP112chr1763848152-95631414805263
ENST00000413366PRKCAchr1764492401+ENST00000537949CEP112chr1763848152-1077314141018334

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000413366ENST00000535342PRKCAchr1764492401+CEP112chr1763848152-0.0004810390.999519
ENST00000413366ENST00000392769PRKCAchr1764492401+CEP112chr1763848152-0.0004877380.9995123
ENST00000413366ENST00000541355PRKCAchr1764492401+CEP112chr1763848152-0.0019016780.9980983
ENST00000413366ENST00000537949PRKCAchr1764492401+CEP112chr1763848152-0.0022210390.99777895

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for PRKCA-CEP112

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
PRKCAchr1764492401CEP112chr1763848152314100FSCPGADKGPDTDVIADMEAQVHKLR

Top

Potential FusionNeoAntigen Information of PRKCA-CEP112 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PRKCA-CEP112_64492401_63848152.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PRKCA-CEP112chr1764492401chr1763848152314HLA-B35:03GPDTDVIADM0.63220.6379818
PRKCA-CEP112chr1764492401chr1763848152314HLA-B35:04GPDTDVIADM0.26510.8102818
PRKCA-CEP112chr1764492401chr1763848152314HLA-B35:02GPDTDVIADM0.26510.8102818
PRKCA-CEP112chr1764492401chr1763848152314HLA-B35:12GPDTDVIADM0.26510.8102818
PRKCA-CEP112chr1764492401chr1763848152314HLA-A68:02DVIADMEAQV0.9970.76131222
PRKCA-CEP112chr1764492401chr1763848152314HLA-A69:01DVIADMEAQV0.9950.91821222
PRKCA-CEP112chr1764492401chr1763848152314HLA-B35:09GPDTDVIADM0.26510.8102818

Top

Potential FusionNeoAntigen Information of PRKCA-CEP112 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PRKCA-CEP112_64492401_63848152.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PRKCA-CEP112chr1764492401chr1763848152314DRB1-0310PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB1-0310DTDVIADMEAQVHKL1025
PRKCA-CEP112chr1764492401chr1763848152314DRB1-0342PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB1-0342DTDVIADMEAQVHKL1025
PRKCA-CEP112chr1764492401chr1763848152314DRB1-1002TDVIADMEAQVHKLR1126
PRKCA-CEP112chr1764492401chr1763848152314DRB1-1476PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB1-1476DTDVIADMEAQVHKL1025
PRKCA-CEP112chr1764492401chr1763848152314DRB1-1479PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB1-1479DTDVIADMEAQVHKL1025
PRKCA-CEP112chr1764492401chr1763848152314DRB1-1525PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB1-1525DTDVIADMEAQVHKL1025
PRKCA-CEP112chr1764492401chr1763848152314DRB3-0101PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB3-0104PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB3-0105PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB3-0108PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB3-0109PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB3-0109DTDVIADMEAQVHKL1025
PRKCA-CEP112chr1764492401chr1763848152314DRB3-0111PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB3-0112PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB3-0113PDTDVIADMEAQVHK924
PRKCA-CEP112chr1764492401chr1763848152314DRB3-0114PDTDVIADMEAQVHK924

Top

Fusion breakpoint peptide structures of PRKCA-CEP112

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
1175DKGPDTDVIADMEAPRKCACEP112chr1764492401chr1763848152314

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of PRKCA-CEP112

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN1175DKGPDTDVIADMEA-7.9962-8.1096
HLA-B14:023BVN1175DKGPDTDVIADMEA-5.70842-6.74372
HLA-B52:013W391175DKGPDTDVIADMEA-6.83737-6.95077
HLA-B52:013W391175DKGPDTDVIADMEA-4.4836-5.5189
HLA-A11:014UQ21175DKGPDTDVIADMEA-10.0067-10.1201
HLA-A11:014UQ21175DKGPDTDVIADMEA-9.03915-10.0745
HLA-A24:025HGA1175DKGPDTDVIADMEA-6.56204-6.67544
HLA-A24:025HGA1175DKGPDTDVIADMEA-5.42271-6.45801
HLA-B44:053DX81175DKGPDTDVIADMEA-7.85648-8.89178
HLA-B44:053DX81175DKGPDTDVIADMEA-5.3978-5.5112
HLA-A02:016TDR1175DKGPDTDVIADMEA-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of PRKCA-CEP112

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
PRKCA-CEP112chr1764492401chr17638481521222DVIADMEAQVGATGTTATTGCCGACATGGAGGCCCAGGTT
PRKCA-CEP112chr1764492401chr1763848152818GPDTDVIADMGGACCCGACACTGATGTTATTGCCGACATG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
PRKCA-CEP112chr1764492401chr17638481521025DTDVIADMEAQVHKLGACACTGATGTTATTGCCGACATGGAGGCCCAGGTTCACAAGTTG
PRKCA-CEP112chr1764492401chr17638481521126TDVIADMEAQVHKLRACTGATGTTATTGCCGACATGGAGGCCCAGGTTCACAAGTTGAGA
PRKCA-CEP112chr1764492401chr1763848152924PDTDVIADMEAQVHKCCCGACACTGATGTTATTGCCGACATGGAGGCCCAGGTTCACAAG

Top

Information of the samples that have these potential fusion neoantigens of PRKCA-CEP112

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADPRKCA-CEP112chr1764492401ENST00000413366chr1763848152ENST00000392769TCGA-VQ-A925-01A

Top

Potential target of CAR-T therapy development for PRKCA-CEP112

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to PRKCA-CEP112

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to PRKCA-CEP112

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource